Endonovo Therapeutics, Inc. (ENDV)
0.0001
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Endonovo Therapeutics Total Liabilities (Quarterly) : 30.09M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 30.09M |
| March 31, 2026 | 29.48M |
| December 31, 2025 | 28.89M |
| September 30, 2025 | 28.35M |
| June 30, 2025 | 27.84M |
| March 31, 2025 | 27.28M |
| December 31, 2024 | 26.82M |
| September 30, 2024 | 26.33M |
| June 30, 2024 | 25.80M |
| March 31, 2024 | 25.28M |
| December 31, 2023 | 24.75M |
| September 30, 2023 | 23.78M |
| June 30, 2023 | 23.22M |
| March 31, 2023 | 25.57M |
| December 31, 2022 | 33.46M |
| September 30, 2022 | 21.06M |
| June 30, 2022 | 20.76M |
| March 31, 2022 | 19.85M |
| December 31, 2021 | 17.78M |
| September 30, 2021 | 20.36M |
| June 30, 2021 | 19.26M |
| March 31, 2021 | 18.49M |
| December 31, 2020 | 16.98M |
| September 30, 2020 | 15.49M |
| June 30, 2020 | 15.08M |
| Date | Value |
|---|---|
| March 31, 2020 | 14.21M |
| December 31, 2019 | 23.78M |
| September 30, 2019 | 19.98M |
| June 30, 2019 | 20.37M |
| March 31, 2019 | 15.39M |
| December 31, 2018 | 15.63M |
| September 30, 2018 | 18.79M |
| June 30, 2018 | 13.40M |
| March 31, 2018 | 13.09M |
| December 31, 2017 | 14.16M |
| September 30, 2017 | 13.34M |
| June 30, 2017 | 9.357M |
| March 31, 2017 | 13.42M |
| December 31, 2016 | 8.880M |
| September 30, 2016 | 8.783M |
| June 30, 2016 | 7.353M |
| March 31, 2016 | 9.287M |
| December 31, 2015 | 9.685M |
| September 30, 2015 | 5.991M |
| June 30, 2015 | 5.452M |
| March 31, 2015 | 4.907M |
| December 31, 2014 | 4.739M |
| September 30, 2014 | 4.583M |
| June 30, 2014 | 5.151M |
| March 31, 2014 | 4.94M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 46.19M |
| Accuray, Inc. | 401.98M |
| Perspective Therapeutics, Inc. | 68.16M |
| Orthofix Medical, Inc. | 443.84M |
| ResMed, Inc. | 2.381B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.0448M |
| Shareholders Equity (Quarterly) | -30.05M |
| Debt to Equity Ratio | -0.2343 |
| Current Ratio | 0.0014 |
| Net Debt Paydown Yield | -1.87K% |